A Breakthrough in Tuberculosis Treatment: Sustained Inhibition of Purine Biosynthesis Yields Promising In Vivo Results Tuberculosis (TB) remains a formidable…
Researchers Uncover Key Mechanism Behind PARP Inhibitor Resistance in BRCA1-Deficient Cancers In a groundbreaking discovery poised to transform cancer therapy,…